Back
Coca-Cola Femsa SAB de CV Vs. Mirum Pharmaceuticals Industry Stock Comparison
Sell
41
KOF
Coca-Cola Femsa SAB de CV
Last Price:
80.45
Seasonality Move:
7.64%
Buy
74
MIRM
Mirum Pharmaceuticals
Last Price:
42.32
Seasonality Move:
40.11%
Sell
41
Coca-Cola Femsa SAB de CV (KOF)
is a Sell
Is Coca-Cola Femsa SAB de CV a Buy, Sell or Hold?
- The current Coca-Cola Femsa SAB de CV [KOF] share price is $81.77. The Score for KOF is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- KOF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
Mirum Pharmaceuticals (MIRM)
is a Buy
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $41.61. The Score for MIRM is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- MIRM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KOF Stock Price Chart
What is Coca-Cola Femsa SAB de CV's stock price today?
-
The Coca-Cola Femsa SAB de CV share price today is $81.77
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KOF is experiencing slight selling pressure.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $41.61
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIRM is experiencing selling pressure, which indicates risk of future bearish movement.
KOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.5 | Sell |
| Relative Strength Index (14 RSI): | 37.83 | Sell |
| Chaikin Money Flow: | -7536 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (82.62 - 87) | Sell |
| Bollinger Bands (100): | (83.92 - 89.28) | Sell |
MIRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.47 | Buy |
| Relative Strength Index (14 RSI): | 60.51 | Buy |
| Chaikin Money Flow: | -203992 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.65 - 40.71) | Buy |
| Bollinger Bands (100): | (36.74 - 42) | Buy |
KOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 82.01 | Sell |
| 20-day SMA: | 84.22 | Sell |
| 50-day SMA: | 86.54 | Sell |
| 200-day SMA: | 91.3 | Sell |
| 8-day EMA: | 82.49 | Sell |
| 20-day EMA: | 83.94 | Sell |
| 50-day EMA: | 85.81 | Sell |
| 200-day EMA: | 88.12 | Sell |
MIRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.72 | Buy |
| 20-day SMA: | 39.9 | Buy |
| 50-day SMA: | 39.98 | Buy |
| 200-day SMA: | 32.84 | Buy |
| 8-day EMA: | 40.9 | Buy |
| 20-day EMA: | 40.21 | Buy |
| 50-day EMA: | 39.72 | Buy |
| 200-day EMA: | 34.91 | Buy |
Coca-Cola Femsa SAB de CV Earnings Growth & KOF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $1.13 per share.
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.71 per share, and an increase next year of $0.88 per share.
Coca-Cola Femsa SAB de CV Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Mirum Pharmaceuticals Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||